Clinical Trial

Study to Evaluate the Safety and the Pharmacokinetics of "UI111" and "UIC202006" Under Fed Conditions

Name: Study to Evaluate the Safety and the Pharmacokinetics of "UI111" and "UIC202006" Under Fed Conditions — clinical trial record (NCT07691268)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

Phase 1 study to evaluate the safety and the pharmacokinetics of "UI111" and "UIC202006" in healthy adult volunteers under fed state conditions \- Open-label, randomized, single-dose, 2-sequence, 4-period, crossover design

Trial Details

NCT Number	NCT07691268
Lead Sponsor	Korea United Pharm. Inc.
Conditions	Dyslipidemia
Enrollment	44 participants
Start Date	2025-02-13
Primary Completion	2025-03-10 (estimated)
Study Completion	2025-03-26 (estimated)
Updated on ClinicalTrials.gov	2026-07-08